Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04872634
What this trial is testing

Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment

Who this might be right for
Non-small Cell Lung Cancer
NKMAX Co., Ltd. 24
Early research (Phase 1)UnknownNCT05276609
What this trial is testing

ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai Hansoh Biomedical Co., Ltd 177
Not applicableNo Longer AvailableNCT04814732
What this trial is testing

Expanded Access Program of Surufatinib

Who this might be right for
Neuroendocrine Tumors
Hutchmed
Testing effectiveness (Phase 2)Looking for participantsNCT05733598
What this trial is testing

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Who this might be right for
Hepatocellular CarcinomaBiliary Tract Cancer
Replimune, Inc. 60
Early research (Phase 1)Study completedNCT01603212
What this trial is testing

Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 6
Post-approval studies (Phase 4)Study completedNCT02447328
What this trial is testing

A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Locally Advanced orMetastatic Breast Cancer
AstraZeneca 83
Testing effectiveness (Phase 2)Ended earlyNCT03573544
What this trial is testing

This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors.

Who this might be right for
Metastatic Solid TumorsLocally Advanced Solid Tumors
OBI Pharma, Inc 54
Early research (Phase 1)Study completedNCT00573495
What this trial is testing

Multipeptide Vaccine for Advanced Breast Cancer

Who this might be right for
Breast NeoplasmBreast CancerCancer of the Breast+1 more
University of Pennsylvania 11
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06250777
What this trial is testing

Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases

Who this might be right for
Non Small Cell Lung Cancer
Yonsei University 27
Testing effectiveness (Phase 2)Study completedNCT00077857
What this trial is testing

Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 470
Testing effectiveness (Phase 2)Study completedNCT00003907
What this trial is testing

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Who this might be right for
Liver CancerMetastatic Cancer
Eastern Cooperative Oncology Group 50
Early research (Phase 1)Study completedNCT00770536
What this trial is testing

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

Who this might be right for
CancerCarcinomaFallopian Tube Cancer+6 more
Amgen 103
Testing effectiveness (Phase 2)Ended earlyNCT03790111
What this trial is testing

A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
TerSera Therapeutics LLC 53
Testing effectiveness (Phase 2)Study completedNCT02414009
What this trial is testing

Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 82
Testing effectiveness (Phase 2)Study completedNCT03555032
What this trial is testing

TITAN (Tumoural Injection of T-VEC and Isolated Limb Perfusion)

Who this might be right for
Melanoma and Sarcoma
Royal Marsden NHS Foundation Trust 15
Testing effectiveness (Phase 2)UnknownNCT05318339
What this trial is testing

Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Carcinoma, Transitional CellHER-2 Gene Amplification
Chinese Academy of Medical Sciences 30
Large-scale testing (Phase 3)Study completedNCT03766295
What this trial is testing

Masitinib Plus Gemcitabine in Pancreatic Cancer

Who this might be right for
Locally Advanced or Metastatic Pancreatic Cancer
AB Science 377
Testing effectiveness (Phase 2)Looking for participantsNCT06341595
What this trial is testing

Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM

Who this might be right for
Gastric CancerGastric Cancer Metastatic to Regional Lymph Nodes
The First Affiliated Hospital with Nanjing Medical University 40
Testing effectiveness (Phase 2)UnknownNCT04180501
What this trial is testing

SRS Sequential Sindilimab in Brain Metastasis of NSLSC

Who this might be right for
NSCLC Stage IVBrain MetastasesSRS+1 more
Xiaorong Dong 25
Large-scale testing (Phase 3)Looking for participantsNCT06956001
What this trial is testing

Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation

Who this might be right for
EGFRNSCLC (Advanced Non-small Cell Lung Cancer)
Allist Pharmaceuticals, Inc. 300
Next Page